Cutaneous sarcoidosis: Complete remission after oral isotretinoin therapy

Acta Dermato-Venereologica

Volumn 78, Issue 6, 1998, Pages 457-459

  Georgiou, S ^a,b   Monastirli, A ^a   Pasmatzi, E ^a   Tsambaos, D ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Granuloma; Retinoids; Skin

Indexed keywords

ISOTRETINOIN;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FOLLOW UP; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REMISSION; SARCOIDOSIS; SKIN DISEASE;

ADMINISTRATION, ORAL; ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOTRETINOIN; KERATOLYTIC AGENTS; REMISSION INDUCTION; SARCOIDOSIS; SKIN DISEASES;

EID: 0031787307     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155598442782     Document Type: Article

References (27)

1. Lever WF, Shaumburg-Lever G. Non-infectious granulomas. In: Lever WF, Schaumburg-Lever G, eds. Histopathology of the skin. 7th ed. Philadelphia: Lippincott, 1990: 252-268.
2. Crystal RG. Sarcoidosis. In: Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, et al., eds. Principles of internal medicine. 12th ed. 1991: 1463-1469.
3. Galanaud P. The in vivo expression of cytokine genes in humans. J Lipid Mediat Cell Signal 1994; 9: 37-41.
4. Garlepp MJ, Rose AH, Denen JF, Robinson BW. Clonal analysis of lung and blood T-cells in patients with sarcoidosis. Thorax 1994; 49: 577-585.
5. Müller-Quernheim J. Immunologische Zellaktivierungen bei Sarkoidose: Immunpathogenetische und klinische Implikationen. Immun Infect 1995; 23: 80-85.
6. Lessana-Leibowitch M, Monsuez JJ, Noble JP, Sedel D, Cadot M, Hewitt J. Manifestations cutanées de la sarcoidose. Ann Med Interne 1984; 135: 97-101.
7. Siltzbach LE, Teirstein AS. Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis. Acta Med Scand Suppl 1964; 425: 302-306.
8. Veien NK, Brodthagen H. Cutaneous sarcoidosis treated with methotrexate. Br J Dermatol 1977; 97: 213-216.
9. Muthiah MM, Macfarlane JT. Current concepts in the management of sarcoidosis. Drugs 1990; 40: 231-237.
10. Waldinger THP, Ellis CHN, Quint K, Voorhees JJ. Treatment of cutaneous sarcoidosis with isotretinoin. Arch Dermatol 1983; 119: 1003-1005.
11. Vaillant L, Le Marchand D, Bertrand S, Grangeponte MC, Lorette G. Sarcoidose cutanée annulaire du front: traitement par isotretinoine. Ann Dermatol Venereol 1986; 113: 1089-1092.
12. Peck GL, Olsen TG, Yoder FW, Strauss JS, Downing DT, Pandya M, et al. Prolonged remissions of cystic and conglobate acne with 13-cis retinoic acid. N Engl J Med 1979; 300: 329-333.
13. Tsambaos D, Orfanos CE. Chemotherapy of psoriasis and other skin disorders with oral retinoids. In: Baden HP, ed. The chemotherapy of psoriasis. International encyclopedia of pharmacology and therapeutics. New York: Pergamon Press, 1984: 287-308.
14. Sidell N, Connor MJ, Chang B, Lowe NJ, Borok M. Effects of 13-cis retinoic acid therapy on human antibody responses to defined protein antigens. J Invest Dermatol 1990; 95: 597-602.
15. Prabhala RH, Garewal HS, Hicks MJ, Sampliner RF, Watson RP. The effects of 13-cis retinoic acid and beta-carotene on cellular immunity in humans. Cancer 1991; 67: 1556-1560.
16. Tsambaos D, Zimmermann B. Effects of synthetic retinoids on cellular systems. In: Roenigk H, Maibach H, eds. Psoriasis. 2nd ed. New York: Marcel Dekker, 1991: 659-707.
17. Chaidaroglou A, Degiannis D, Koniavitou K, Georgiou S, Tsambaos D. In vitro elfects of retinoids on peripheral blood leukocyte response to mitogens. Arch Dermatol Res 1998; 290: 205-210.
18. Bonta IL, Parnham MJ. Macrophages as targets of inhibitory effects of E-type prostaglandins in immune-related inflammation. Agents Actions 1981; 11: 594-597.
19. Kunkel SL, Fantone JC, Ward PA, Zurier RB. Modulation of inflammatory reactions by prostaglandins. Prog Lipid Res 1982; 20: 633-640.
20. Chensue SW, Kunkel SL, Ward PA, Higashi GI. Exogenous administered prostaglandins modulate pulmonary granulomas induced by Schistosoma mansoni eggs. Am J Pathol 1983; 111: 78-87.
21. Wolter NJ, Kunkel WL, Lynch JP, Ward PA. Production of cyclooxygenase products by alveolar macrophages in pulmonary sarcoidosis. Chest 1983; 83 (Suppl): 79-81.
22. Nakayama T, Hashimoto S, Amemiya E, Horie T. Elevation of plasma-soluble tumour necrosis factor receptors (TNF-R) in sarcoidosis. Clin Exp Immunol 1996; 104: 318-324.
23. Shikama Y, Kobayashi K, Yamagata N. Augmentation of pulmonary foreign body granulomatous inflammation in mice by lipopolysaccharide: involvement of macrophage activation and tumor necrosis factor-α Am J Pathol 1989; 134: 1189-1199.
24. Terao I, Hashimoto S, Horie T. Effect of GM-CSF on TNF-alpha and IL-1 beta production by alveolar macrophages and peripheral blood monocytes from patients with sarcoidosis. Int Arch Allergy Immunol 1993; 102: 242-248.
25. Levine L, Ohuchi K, Retinoids as well as tumor promoters enhance deacylalion of cellular lipids and prostaglandin production in MDCK cells. Nature 1978; 276: 274-275.
26. Mehta K, McQueen T, Tucker S, Pandita R, Aggarwal BB. Inhibition by all-trans-retinoic acid of tumor necrosis factor and nitric oxide production by peritoneal macrophages. J Leukoc Biol 1994; 55: 336-342.
27. Totpal K, Chaturvedi MM, La Pushin R, Aggarwal BB. Retinoids downregulate both p60 and p80 forms of tumor necrosis factor receptors in human histiocytic lymphoma U-937 cells. Blood 1995; 85: 3547-3555.